By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VBL Therapeutics 

6 Jonathan Netanyahu Street

Or Yehuda    60376  Israel
Phone: 97-236-346450 Fax: 97-236-346449


SEARCH JOBS


Industry
Biotechnology






Company News
VBL Therapeutics (VBLX) Announces Positive Phase 2a Data For VB-111 In Recurrent Thyroid Cancer 12/22/2014 7:16:37 AM
VBL Therapeutics (VBLX) Announces Last Patient Out In Phase 2 Clinical Studies Of VB-201 In Psoriasis And Ulcerative Colitis 12/15/2014 7:19:53 AM
VBL Therapeutics (VBLX) To Present Company Overview At Upcoming Conferences 11/25/2014 11:30:06 AM
VBL Therapeutics (VBLX) Announces Third Quarter 2014 Financial Results 11/13/2014 10:22:53 AM
VBL Therapeutics (VBLX) To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At 19th Annual Scientific Meeting Of The Society For Neuro-Oncology (SNO) 11/13/2014 7:30:35 AM
VBL Therapeutics (VBLX) To Report Third Quarter 2014 Financial Results On November 13, 2014 11/3/2014 8:43:41 AM
VBL Therapeutics (VBLX) To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At 19th Annual Scientific Meeting Of The Society For Neuro-Oncology (SNO) 11/3/2014 7:24:36 AM
VBL Therapeutics (VBLX) Announces Closing Of Initial Public Offering 10/7/2014 7:27:48 AM
VBL Therapeutics (VBLX) Announces Pricing Of Initial Public Offering 10/1/2014 7:52:37 AM
Israel's VBL Therapeutics (VBLX) Terminates NASDAQ IPO Due To Shareholder Mishap 8/8/2014 11:10:59 AM
12345
//-->